The entire 36-week data for the remaining subjects in the trial is anticipated in the second quarter of this year.

Coloradans will soon have legal access to psychedelic-assisted therapy with the first licensed psilocybin businesses expected ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

This certification enables businesses to highlight their achievements in inclusive hiring and embed structured, ...

If happiness is connected to larger anti-democratic trends, then America's future is dire ...

Charles C. Wykoff, MD, PhD, Retinal Consultants of Texas, discusses data supporting the FDA approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals), the first and only therapy ...

Hubble Therapeutics LLC a patient-focused biotechnology company developing a gene therapy to cure pediatric blindness, announces the successful ...

CET / 3:00am ET - Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah” or the "Company”), that develops breakthrough ...

Mobility matters because it allows us to live independently and participate fully in our everyday activities for as long as ...

Olivet Baptist Church Health/Nursing Ministry observed Purple Day - Epilepsy Awareness Day - last Saturday at the church. Dr. Cleopatra Thurman, vascular neurologist and Erlanger' s Stroke Program ...

The NASA astronaut was stuck in space for over 9 months (286 days appoximately). Although she is back on Earth, her body is ...